Sold out
Vichy Normaderm Anti-blemish Corrective Care Cream for Oily/Acne Skin with Salicylic Acid – 50ml
US$25.00
A Correcting Anti-Blemish Care Moisturiser targets concerns and provided 24 hour hydration.
The blemish control moisturiser is enriched with an ultra-light substance called Airlicium, an innovation that works to disperse and absorb sebum. Combined with mattifying ingredients it gives skin a soft focus effect whilst reducing the appearance of pores. The formula also contains LHA: Salicylic Acid (1.5%), which targets oily skin and helps the skin look radiant and beautiful.
Your order qualifies for free shipping!
Out of stock
Want to be notified when this product is back in stock?
EAN: 3337875414111
SKU:
VCY009
Categories: Cream, dark spots, Day, Face care, Large Pores, Light, Loss Of Radiance, Men, Oil Control, Skin Care, Vichy, Women, Brand, Care Type, Hydration, Acne, Combination Skin, Oily Skin, Salicylic Acid
Tag: Blemish _Acne-Free_Skin_Gifts
Description
Description
A Correcting Anti-Blemish Care Moisturiser targets concerns and provided 24 hour hydration.
Key Benefits:
1- Combats signs of imperfection-prone skin and immediately starts working to clear concerns, including hormonal blemishes
2- Skin looks radiant, hydrated and beautiful
3- Light texture, non-greasy and non-sticky
4- Ideal make-up base
5- Provides up to 24 hours hydration
Suitable for sensitive skin
Tested on sensitive skin under dermatological control
Hypoallergenic
Key Ingredients:
1- Salicylic Acid (1.5%): targets oily skin and helps the skin look radiant and beautiful.
2- Vichy Mineralizing Water
3- Airlicium
How to Use:
Use Normaderm Correcting Anti-Blemish Care Moisturiser morning or evening to moisturise the face after Minéral 89.
Visible Results:
Leaves skin feeling mattified, comfortable and hydrated for 24 hours.
Reviews (0)
Be the first to review “Vichy Normaderm Anti-blemish Corrective Care Cream for Oily/Acne Skin with Salicylic Acid – 50ml” Cancel reply
You must be logged in to post a review.
Reviews
There are no reviews yet.